FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

Voluntary Recall Alert
November 13, 2020

Voluntary Recall Alert for Chlorhexidine Gluconate Oral Rinse
Due to Microbial Contamination Continue reading


The Annual Report and Long-Range Plan Released for Fiscal Year 2019-2020
October 30, 2020

The Annual Report and Long-Range Plan for Fiscal Year 2019-2020
is now online. Continue reading